Our predictors of interest were estimates of GFR by creatinine and cystatin C (GFRcystatin C) and albuminuria expressed as ACR. Blood was collected from participants during an in-home examination after a 12-hour fast. Serum creatinine was measured and calibrated to isotope dilution mass spectrometry-traceable methods.21 (link) Cystatin C was measured by particle-enhanced immunonephelometry (N Latex Cystatin C on the BNII, Formerly, Dade Behring, Now Siemens AG, Munich, Germany).13 (link) Urine albumin was measured by nephelometry using the BNII ProSpec nephelometer (Now Siemens AG), and urine creatinine by the Jaffe method using the Modular-P chemistry analyzer (Roche/ Hitachi, Basel, Switzerland).
We defined stage 3 or higher CKD as an estimated GFR of less than 60 mL/min/1.73 m2 using the CKD Epidemiology Collaboration (CKD-Epi) equation for creatinine22 (link):
EstimatedGFRcreatinine=141×minimum(serumcreatinine/k,1)a×maximum(serumcreatinine/k,1)-1.209×0.993age×1.018[iffemale]×1.159[ifblack] and the CKD-Epi cystatin C equation:
estimatedGFRcystatinC=76.7×cystainC-1.19
The cystatin C formula was developed from the pooling of several cohorts with GFR measured by iothalamate.23 (link)We defined albuminuria as a spot urine ACR of 30 mg/g or higher.1 (link)